Catalyst Wire Dossier Catalyst Wire Dossier

bifikafusp alfa

bifikafusp alfa · Philogen S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bifikafusp alfa, covering 2025-10-01 to 2025-10-01. Get the full timeline:

Most recent: EMA Application withdrawn: Nidlegy (bifikafusp alfa;onfekafusp alfa) — Philogen S.p.A.

See pricing